Search research articles
Contact Us
Filters
Showing results (191-200 of 201) with videos related to
Page
of 21
Sort By:
Clinical Pharmacology and Therapeutics
|
July 1, 1986
Encainide disposition in patients with renal failure
R H Bergstrand, T Wang, D M Roden, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1996
Determination of dextromethorphan metabolic phenotype by salivary analysis with a reference to genotype in Chinese patients receiving renal hemodialysis
Z Y Hou, C P Chen, W C Yang, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1989
Recainam dose titration and pharmacokinetics in patients with resistant arrhythmias
R F Davies, M D Lineberry, C Funck-Brentano, et al.
The New England Journal of Medicine
|
June 21, 1990
The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone
J T Lee, H K Kroemer, D J Silberstein, et al.
Annals of Surgery
|
June 1, 1986
Indications for different modes of surgical therapy in medically refractory ventricular arrhythmias
J W Hammon, D S Echt, W H Merrill, et al.
The Physiologist
|
June 1, 1994
The essential role of integrative biomedical sciences in protecting and contributing to the health and well-being of our nation
P C Jobe, L E Adams-Curtis, T F Burks, et al.
Journal of the American College of Cardiology
|
December 1, 1983
Electrophysiologic actions of high plasma concentrations of propranolol in human subjects
H J Duff, D M Roden, L Brorson, et al.
The Journal of Clinical Investigation
|
March 1, 1990
Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade
K T Murray, C Reilly, R P Koshakji, et al.
The American Journal of Cardiology
|
December 1, 1981
Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide
H J Duff, D M Roden, R J Maffucci, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1986
Encainide disposition in patients with chronic cirrhosis
R H Bergstrand, T Wang, D M Roden, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 201) with videos related to
Sort By:
Page
of 21
Clinical Pharmacology and Therapeutics
|
July 1, 1986
Encainide disposition in patients with renal failure
R H Bergstrand, T Wang, D M Roden, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 1996
Determination of dextromethorphan metabolic phenotype by salivary analysis with a reference to genotype in Chinese patients receiving renal hemodialysis
Z Y Hou, C P Chen, W C Yang, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1989
Recainam dose titration and pharmacokinetics in patients with resistant arrhythmias
R F Davies, M D Lineberry, C Funck-Brentano, et al.
The New England Journal of Medicine
|
June 21, 1990
The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone
J T Lee, H K Kroemer, D J Silberstein, et al.
Annals of Surgery
|
June 1, 1986
Indications for different modes of surgical therapy in medically refractory ventricular arrhythmias
J W Hammon, D S Echt, W H Merrill, et al.
The Physiologist
|
June 1, 1994
The essential role of integrative biomedical sciences in protecting and contributing to the health and well-being of our nation
P C Jobe, L E Adams-Curtis, T F Burks, et al.
Journal of the American College of Cardiology
|
December 1, 1983
Electrophysiologic actions of high plasma concentrations of propranolol in human subjects
H J Duff, D M Roden, L Brorson, et al.
The Journal of Clinical Investigation
|
March 1, 1990
Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade
K T Murray, C Reilly, R P Koshakji, et al.
The American Journal of Cardiology
|
December 1, 1981
Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide
H J Duff, D M Roden, R J Maffucci, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1986
Encainide disposition in patients with chronic cirrhosis
R H Bergstrand, T Wang, D M Roden, et al.
Page
of 21